Vialwirebiotech, curated
August 16, 2026, 1:29 PM
August 14, 2026
- 12:00 PM · BioWorld12:00 PMURAT1 contender: JW eyes Korea NDA after gout drug’s phase III — BioWorld
- 12:00 PM · BioWorld12:00 PMClaret provides €30M funding for Carvolix growth plans — BioWorld
- 9:51 AM · PharmaVoice9:51 AMBMS builds big in Texas; Regeneron backs would-be rival — PharmaVoice
- 9:28 AM · BioPharma Dive9:28 AMCapricor shares spike on CEO comments; Cytokinetics sues Bristol Myers — BioPharma Dive
- 9:23 AM · STAT News
- 9:00 AM · BioWorld9:00 AMThe United Bio-Technology presents new GLP-1R agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMNIAID contract advances Arisan’s Ebola antiviral — BioWorld
- 9:00 AM · BioWorld9:00 AMImpact Therapeutics discloses new dual Wee1/PKMYT1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMD3 Bio synthesizes new pan-KRAS inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMAllist signs China license agreement for ARR-002 — BioWorld
- 9:00 AM · BioWorld9:00 AMDogwood Therapeutics’ SP-16 gains IND clearance — BioWorld
- 9:00 AM · BioWorld9:00 AMNew BTK degradation inducers reported in Hengrui patent — BioWorld
- 9:00 AM · BioWorld9:00 AMChengdu Mfs Pharma identifies new ester heterocyclic compounds — BioWorld
- 8:59 AM · PharmaVoice8:59 AMBioNTech’s oncology pivot comes with a new CEO — PharmaVoice
- 8:03 AM · STAT News
- 7:00 AM · Drug Discovery World7:00 AMSkylark initiates trial of gene therapy for hearing loss — Drug Discovery World
- 6:08 AM · Pharmaceutical Technology6:08 AMImmunology specialist Khartis Therapeutics emerges from stealth with $95m — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMSentynl expands rare disease portfolio with alvelestat purchase — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMUK first in Europe to authorise Lilly’s weight loss tablet orforglipron — Drug Discovery World
- 4:42 AM · Pharmaceutical Technology4:42 AMXanadu and University of Alberta to develop quantum algorithms for cancer — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMCharities donate $5.5m to expand access to rare disease treatment — Drug Discovery World
- 2:30 AM · Science (News)2:30 AMNIH is ending a key grant for budding clinical researchers — Science (News)
August 13, 2026
- 12:05 PM · BioPharma Dive12:05 PMNew Taiho, Cullian data heats up lung cancer drug battle — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAntibody fever in Indupro’s $77M series B, Boulevard‘s $65M launch — BioWorld
- 12:00 PM · BioWorld12:00 PMStaar wars end, PTC victor; Fabry drug Lukes viable — BioWorld
- 12:00 PM · BioWorld12:00 PMWomen's health funding up, but only a drop in an ocean of opportunity — BioWorld
- 12:00 PM · BioWorld12:00 PMSilence draws upsized $175M after divesiran’s phase II PV win — BioWorld
- 9:26 AM · Drug Discovery World9:26 AMCN Bio awarded Innovate UK grant to reduce animal testing — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMChina NMPA clears Ark’s AK-0406 for clinic for influenza prophylaxis — BioWorld
- 9:00 AM · BioWorld9:00 AMInsilico Medicine nominates ISM-0900 as cardiovascular candidate — BioWorld
- 6:20 AM · Pharmaceutical Technology6:20 AMRepligen’s deal for BioLife Solutions indicates shift to manufacturing integration — Pharmaceutical Technology
- 6:02 AM · Pharmaceutical Technology6:02 AMAkeso secures China NMPA authorisation for ivonescimab combo — Pharmaceutical Technology
- 5:06 AM · Pharmaceutical Technology5:06 AMRemepy secures $36m funding for hybrid drug pipeline expansion — Pharmaceutical Technology
- 4:10 AM · Drug Discovery World4:10 AMRadiotherapeutic study shows low exposure to healthy organs — Drug Discovery World
August 12, 2026
- 4:47 PM · Bloomberg — Technology4:47 PMFermi Names McIntire CEO Four Months After Ousting Co-Founder — Bloomberg — Technology
- 4:46 PM · STAT News4:46 PMTalks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says — STAT News